Compound Report Overview
Compound Name:
VADOCAINE
Compound Identifier:
702144
Mol Structure 2D:
702144
Molecular Weight:
304
Formula:
C18 H28 N2 O2
Development Status:
Preclinical
SMILES:
COc1cc(C)cc(C)c1NC(=O)CCN2CCCCC2C
Compound Targets
| Compound | Gene | Gene Type | View |
|---|---|---|---|
| VADOCAINE | 150734 | sodium channel, voltage-gated, type V, alpha polypeptide | View |
| VADOCAINE | 165452 | sodium channel, voltage-gated, type II, beta | View |
| VADOCAINE | 165421 | sodium channel, voltage-gated, type IX, alpha | View |
| VADOCAINE | 165479 | sodium channel, voltage-gated, type 2, alpha 1 polypeptide | View |
| VADOCAINE | 165775 | sodium channel, voltage-gated, type VIII, alpha polypeptide | View |
| VADOCAINE | 127667 | sodium channel, voltage-gated, type 10, alpha polypeptide | View |
| VADOCAINE | 127751 | sodium channel, nonvoltage-gated 1 gamma | View |
| VADOCAINE | 133117 | sodium channel, voltage-gated, type I, alpha | View |
| VADOCAINE | 168887 | amiloride-sensitive cation channel 5, intestinal | View |
| VADOCAINE | 135381 | sodium channel, voltage-gated, type VII, alpha | View |
| VADOCAINE | 135191 | sodium channel, voltage-gated, type I, beta | View |
| VADOCAINE | 137182 | sodium channel, voltage-gated, type IV, alpha polypeptide | View |
| VADOCAINE | 132900 | sodium channel, voltage-gated, type XI, alpha | View |
| VADOCAINE | 153849 | sodium channel, nonvoltage-gated 1 alpha | View |
| VADOCAINE | 153848 | sodium channel, nonvoltage-gated 1 beta | View |